OTC Drug & Dietary Supplement Trends and Forecast
The future of the global OTC drug & dietary supplement market looks promising with opportunities in the tablets, hard capsules, powders, ointments, soft capsules, and liquids markets. The global OTC drug & dietary supplement market is expected to reach an estimated $256.13 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing awareness concerning general health issues and rising demand for personalized medicine for treating minor ailments.OTC Drug & Dietary Supplement by Segment
The study includes a forecast for the global OTC drug & dietary supplement by dosage form, distribution channel, product, category, and region.OTC Drug & Dietary Supplement Market by Dosage Form [Shipment Analysis by Value from 2018 to 2030]:
- Tablets
- Hard Capsules
- Powders
- Ointments
- Soft Capsules
- Liquids
- Others
OTC Drug & Dietary Supplement Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
- Pharmacies
- Grocery Stores
- Vitamin & Health Food Stores
- Online Pharmacy
- Others
OTC Drug & Dietary Supplement Market by Product [Shipment Analysis by Value from 2018 to 2030]:
- Branded Drugs
- Generic Drugs
OTC Drug & Dietary Supplement Market by Category [Shipment Analysis by Value from 2018 to 2030]:
- Vitamin & Dietary Supplements
- Cough & Cold Products
- Analgesics
- Gastrointestinal Products
- Sleep Aids
- Otic Products
- Wart Removers
- Mouth Care Products
- Ophthalmic Products
- Others
OTC Drug & Dietary Supplement Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of OTC Drug & Dietary Supplement Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies OTC drug & dietary supplement companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the OTC drug & dietary supplement companies profiled in this report include:- Johnson & Johnson
- Pfizer
- Sanofi
- Roche
- AstraZeneca
- GlaxoSmithKline
- Novartis
- Merck & Co.
- Bayer Healthcare
- Gilead Sciences
OTC Drug & Dietary Supplement Market Insights
The publisher forecasts that generic drugs is expected to witness the higher growth over the forecast period.Within this market, tablets will remain the largest segment.
North America is expected to witness highest growth over the forecast period.
Features of the Global OTC Drug & Dietary Supplement Market
- Market Size Estimates: OTC drug & dietary supplement market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: OTC drug & dietary supplement market size by various segments, such as by dosage form, distribution channel, product, category, and region in terms of value ($B).
- Regional Analysis: OTC drug & dietary supplement market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different dosage forms, distribution channels, products, categories, and regions for the OTC drug & dietary supplement market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the OTC drug & dietary supplement market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the OTC drug & dietary supplement market size?Answer: The global OTC drug & dietary supplement market is expected to reach an estimated $256.13 billion by 2030.
Q2. What is the growth forecast for OTC drug & dietary supplement market?
Answer: The global OTC drug & dietary supplement market is expected to grow with a CAGR of 5.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the OTC drug & dietary supplement market?
Answer: The major drivers for this market are increasing awareness concerning general health issues and rising demand for personalized medicine for treating minor ailments.
Q4. What are the major segments for OTC drug & dietary supplement market?
Answer: The future of the OTC drug & dietary supplement market looks promising with opportunities in the tablets, hard capsules, powders, ointments, soft capsules, and liquids markets.
Q5. Who are the key OTC drug & dietary supplement market companies?
Answer: Some of the key OTC drug & dietary supplement companies are as follows:
- Johnson & Johnson
- Pfizer
- Sanofi
- Roche
- AstraZeneca
- GlaxoSmithKline
- Novartis
- Merck & Co.
- Bayer Healthcare
- Gilead Sciences
Answer: The publisher forecasts that generic drugs is expected to witness the higher growth over the forecast period.
Q7. In OTC drug & dietary supplement market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the OTC drug & dietary supplement market by dosage form (tablets, hard capsules, powders, ointments, soft capsules, liquids, and others), distribution channel (pharmacies, grocery stores, vitamin & health food stores, online pharmacy, and others), product (branded drugs and generic drugs), category (vitamin & dietary supplements, cough & cold products, analgesics, gastrointestinal products, sleep aids, otic products, wart removers, mouth care products, ophthalmic products, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Johnson & Johnson
- Pfizer
- Sanofi
- Roche
- AstraZeneca
- GlaxoSmithKline
- Novartis
- Merck & Co.
- Bayer Healthcare
- Gilead Sciences
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...